The goal of this research proposal is to quantify basal and insulin-stimulated glucose disposal during insulin clamp studies. This will be done by determining glucose utilization at basal insulin concentrations (equal 10 muU/ml) and at steady-state plasma insulin concentrations of equal 60 muU/ml. The difference between these two values provides a direct estimate of the ability of insulin to promote glucose uptake. This approach will be used to compare basal and insulin-stimulated glucose uptake in normal subjects and in patients with non-insulin dependent diabetes mellitus (NIDDM), as well as defining the effect of variations in degree of obesity and level of habitual physical activity on these two facets of glucose disposal in experimental groups. In addition, basal and insulin-stimulated glucose uptake will be quantified before and after treatment of NIDDM with either weight reduction, sulfonylurea, or exogenous insulin. Finally, isolated adipocytes will be used to quantify basal and insulin-stimulated glucose uptake in all of the above situations, and attempts will be made to correlate these estimates of in vitro glucose metabolism with the in vivo results.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030732-05
Application #
3229619
Study Section
Metabolism Study Section (MET)
Project Start
1983-01-01
Project End
1991-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Abbasi, Fahim; Chu, James W; McLaughlin, Tracey et al. (2004) Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Metabolism 53:159-64
Chu, James W; Abbasi, Fahim; Beatty, George W et al. (2003) Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism 52:858-61
McLaughlin, T; Abbasi, F; Lamendola, C et al. (2001) Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. Metabolism 50:819-24
Santos, R F; Nomizo, R; Oliveira, E et al. (2000) Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control. Diabetes Obes Metab 2:237-41
Abbasi, F; McLaughlin, T; Lamendola, C et al. (2000) The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers. J Clin Endocrinol Metab 85:1251-4
Rosolova, H; Mayer Jr, O; Reaven, G M (2000) Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 49:418-20
Abbasi, F; McLaughlin, T; Lamendola, C et al. (2000) Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Metabolism 49:151-4
Chen, N G; Reaven, G M (1999) Fatty acid inhibition of glucose-stimulated insulin secretion is enhanced in pancreatic islets from insulin-resistant rats. Metabolism 48:1314-7
Abbasi, F; Carantoni, M; Chen, Y D et al. (1998) Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care 21:1301-5
Maheux, P; Chen, Y D; Polonsky, K S et al. (1997) Evidence that insulin can directly inhibit hepatic glucose production. Diabetologia 40:1300-6

Showing the most recent 10 out of 46 publications